You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resistance mechanism

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carbapenem-Resistant Enterobacteriaceae Infection Trial in Jinan (CAZ/AVI plus Aztreonam, Conventional treatment)

Recruiting
  • Carbapenem-Resistant Enterobacteriaceae Infection
  • CAZ/AVI plus Aztreonam
  • Conventional treatment
  • Jinan, Shandong, China
    Mingju Hao
Apr 29, 2023

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Cirrhosis, Liver Trial in Cleveland (Endurance Training 3 times per week, Resistance Exercise, Standard of Care)

Recruiting
  • Cirrhosis, Liver
  • Endurance Training 3 times per week
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic
Aug 8, 2023

Microenvironment of Lung Cancer and Exploration of Mechanism of

Recruiting
  • Lung Cancer
  • Multiomics analysis
  • Yiwu, Zhejiang, China
    The Fourth Affiliated Hospital of Zhejiang University
Dec 16, 2022

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

The Role of B7-H4 in Tumor Vaccine

Recruiting
  • Glioma
  • tumor vaccine
  • Shanghai, Shanghai, China
    Di Chen
Nov 26, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab, Paclitaxel, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Mar 6, 2022

Resistance to GNC-038 in Relapsed and Refractory Diffuse Large

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Apr 17, 2022

    Resistance in Carbapenemase-producing Enterobacterales and

    Enrolling by invitation
    • Bacterial Infections
    • Antibiotic Resistant Infection
    • No intervention
    • Rio De Janeiro, Brazil
      D'Or Institute for Research and Education (IDOR)
    Mar 16, 2022

    PCOS Trial in Changsha (Modified Supper Long Protocol)

    Terminated
    • PCOS
    • Modified Supper Long Protocol
    • Changsha, Hunan, China
      Reproductive & Genetic Hospital of CITIC-XIANGYA
    Jan 9, 2022

    Insulin Sensitivity Trial in San Antonio (Sevelamer, Synbiotic, Maltodextrin)

    Completed
    Has Results
    • Insulin Sensitivity
    • San Antonio, Texas
      Audie L. Murphy VA Hospital, STVHCS
    Sep 15, 2021

    Hypertension Trial in Dallas (DEFINITY® infusion, Human Recombinant Regular Insulin infusion, Dextrose infusion)

    Recruiting
    • Hypertension
    • DEFINITY® infusion
    • +6 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Mar 22, 2022

    Lung Cancer, Non-small Cell, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial in Changsha (Genomic profiles detection,

    Recruiting
    • Lung Cancer, Non-small Cell
    • +4 more
    • Genomic profiles detection
    • circulating tumor DNA detection
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Oct 25, 2022

    Allergic Asthma Trial (House dust mite)

    Withdrawn
    • Allergic Asthma
    • House dust mite
    • (no location specified)
    Jul 27, 2021

    Insulin Sensitivity Trial in San Antonio (Maltodextrin, Synbiotic, Sevelamer)

    Completed
    Has Results
    • Insulin Sensitivity
    • San Antonio, Texas
      Audie L. Murphy VA Hospital, STVHCS
    Aug 26, 2020

    RAS Wild-type mCRC Resistance to Anti-EGFR-antibody

    Completed
    • Colorectal Cancer
      • Guanzhou, Guangdong, China
        Medical Oncology,Sun Yat-sen University Cancer Center
      Jul 6, 2020

      ALK Positive NSCLC Trial in Guangzhou (Loratinib)

      Recruiting
      • ALK Positive Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial Perople's Hospital
      Oct 19, 2023

      NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

      Not yet recruiting
      • Non-Small Cell Lung Cancer Metastatic
      • Seoul, Gangnam-gu, Korea, Republic of
        Samsung Medical Center
      Oct 27, 2023

      NSCLC Trial (Lazertinib group)

      Not yet recruiting
      • NSCLC
      • Lazertinib group
      • (no location specified)
      Jul 14, 2022

      Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

      Recruiting
      • Ovarian Cancer
        • Seoul, Korea, Republic of
          Yonsei University Health System, Severance Hospital
        Jul 13, 2022

        Antimicrobial Resistance in Hospitals From Meta, Colombia

        Not yet recruiting
        • Increased Drug Resistance
        • Factors associated
        • Villavicencio, Meta, Colombia
          Hospital Departamental de Villavicencio
        Sep 16, 2023

        Plasma NGS for Assessment, Characterization, Evaluation of ALK

        Active, not recruiting
        • Non-Small Cell Lung Cancer
        • Plasma Next Generation Sequencing (NGS)
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Jan 26, 2023

        First Line Crizotinib in ROS1 Rearranged Advanced Non-squamous

        Recruiting
        • Non-small Cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer Hospital
        Mar 1, 2022

        Studying Pathways of Resistance in KRAS-driven Cancers

        Not yet recruiting
        • KRAS P.G12C
        • FoundationOne® Liquid CDx
        • (no location specified)
        Mar 9, 2022

        Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

        Not yet recruiting
        • Polycystic Ovary Syndrome
        • SGLT2 inhibitors combined with metformin
        • Placebo combined with metformin
        • (no location specified)
        Jul 21, 2023